for the 3' end of the bcn region were used as probes.' Insert DNA was isolated from the plasmid by restriction enzyme digest and electrophoresis in low melting-point agarose (Sea Plaque, FMC, Rockville, ME).
After two phenol-one chloroform extractions, the DNA was ethanol precipitated.
The 3' bcr probe was obtained from Oncogene
Science,
Inc. Mineola, NY, and was used as whole plasmid. DNA was labeled with the Amersham multipnime kit to specific activities of 3 x 10' to tO' cpm/zg DNA following a protocol from Feinbeng and Vogelstein." Hybridization was performed in 50% formamide, 5
x SSC, 5 x Denhardts solution,'#{176} i% SDS, 250 ig/mL carrier DNA at 42#{176}C, overnight. Filters were washed twice in 2 x SSC/1% SDS for 1 5 minutes at room temperature and in 0. i x 55C/0.1% SDS at 60#{176}C to 68#{176}C for one hour. Hybridizing bands were detected by autoradiognaphy using Kodak XAR-5 film (Eastman Kodak, Stuttgart, FRG). control human-placenta DNA (Fig 1 A, ..
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allele.
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